-
Journal of the National Cancer Institute Apr 2022
Topics: Contraceptives, Oral; Female; Genes, BRCA1; Genes, BRCA2; Humans; Neoplasms
PubMed: 35048983
DOI: 10.1093/jnci/djac006 -
Tidsskrift For Den Norske Laegeforening... Oct 2017
Topics: Contraceptives, Oral; Female; History, 20th Century; Humans; Norway; Pregnancy
PubMed: 29094558
DOI: 10.4045/tidsskr.17.0665 -
Tidsskrift For Den Norske Laegeforening... Jan 2013
Topics: Contraceptives, Oral, Hormonal; Female; Humans; Menstruation
PubMed: 23344585
DOI: 10.4045/tidsskr.12.1453 -
Postgraduate Medical Journal Dec 1975An association between acute relapsing pancreatitis and the contraceptive pill has recently been suggested (Bank and Marks, 1970; Davidoff, Tishler and Rosoff, 1973). We...
An association between acute relapsing pancreatitis and the contraceptive pill has recently been suggested (Bank and Marks, 1970; Davidoff, Tishler and Rosoff, 1973). We wish to report a further case of acute pancreatitis in a patient taking the pill. In contrast to previous cases the serum lipids were normal and the pancreatitis was severe and ultimately fatal.
Topics: Acute Disease; Adult; Contraceptives, Oral; Female; Humans; Pancreatitis
PubMed: 1208296
DOI: 10.1136/pgmj.51.602.855 -
Journal of Pain and Symptom Management Feb 1993A variety of evidence suggests a link between migraine and the female sex hormones. Women with migraine outnumber men by at least a 2:1 ratio and definite patterns of... (Review)
Review
A variety of evidence suggests a link between migraine and the female sex hormones. Women with migraine outnumber men by at least a 2:1 ratio and definite patterns of development and attacks are noted at menarche and throughout the period of menses, related to trimester of pregnancy, and again at menopause, although it may also regress. Hormonal replacement with estrogen can exacerbate migraine; oral contraceptives can change the character and frequency of migraine headache. This article will cover approaches to the therapy of hormone-related headaches associated with the menstrual cycle, menopause, and oral contraceptives.
Topics: Contraceptives, Oral; Female; Gonadal Steroid Hormones; Humans; Menopause; Menstrual Cycle; Migraine Disorders
PubMed: 8492007
DOI: 10.1016/0885-3924(93)90107-7 -
British Medical Journal (Clinical... Feb 1988
Topics: Contraceptives, Oral; Female; Humans; Postoperative Complications; Preoperative Care; Risk Factors; Thrombophlebitis
PubMed: 3126855
DOI: 10.1136/bmj.296.6620.447 -
American Family Physician Nov 1999Oral contraceptive pills are widely used and are generally safe and effective for many women. The World Health Organization has developed a risk classification system to... (Review)
Review
Oral contraceptive pills are widely used and are generally safe and effective for many women. The World Health Organization has developed a risk classification system to help physicians advise patients about the safety of oral contraceptive pills. The choice of pill formulation is influenced by clinical considerations. By choosing appropriately from the available pill formulations, family physicians can minimize negative side effects and maximize noncontraceptive benefits for their patients. Additional monitoring and follow-up are necessary in special populations, such as women over 35 years of age, smokers, perimenopausal women and adolescents. Third-generation progestins are additional options for achieving noncontraceptive benefits, but their use has raised new questions about thrombogenesis. The U.S. Food and Drug Administration has labeled emergency postcoital contraception for use following unprotected coitus. Oral contraceptive pills are associated with few clinically significant drug interactions, although consideration of interactions remains important.
Topics: Adolescent; Adult; Chemistry, Pharmaceutical; Contraceptives, Oral; Contraceptives, Postcoital; Contraindications; Drug Interactions; Female; Humans; Risk; World Health Organization
PubMed: 10569509
DOI: No ID Found -
American Family Physician May 2004Acne can cause significant embarrassment and anxiety in affected patients. It is important for family physicians to educate patients about available treatment options... (Review)
Review
Acne can cause significant embarrassment and anxiety in affected patients. It is important for family physicians to educate patients about available treatment options and their expected outcomes. Topical retinoids, benzoyl peroxide, sulfacetamide, and azelaic acid are effective in patients with mild or moderate comedones. Topical erythromycin or clindamycin can be added in patients with mild to moderate inflammatory acne or mixed acne. A six-month course of oral erythromycin, doxycycline, tetracycline, or minocycline can be used in patients with moderate to severe inflammatory acne. A low-androgen oral contraceptive pill is effective in women with moderate to severe acne. Isotretinoin is reserved for use in the treatment of the most severe or refractory cases of inflammatory acne. Because of its poor side effect profile and teratogenicity, isotretinoin (Accutane) must by prescribed by a physician who is a registered member of the manufacturer's System to Manage Accutane-Related Teratogenicity program.
Topics: Acne Vulgaris; Anti-Bacterial Agents; Contraceptives, Oral; Humans; Retinoids
PubMed: 15152959
DOI: No ID Found -
BMJ (Clinical Research Ed.) Apr 1989
Review
Topics: Cardiovascular Diseases; Contraceptives, Oral; Female; Humans; Lipid Metabolism; Risk Factors
PubMed: 2497884
DOI: 10.1136/bmj.298.6680.1049 -
Hormone Research in Paediatrics 2017Hormone replacement therapy (HRT) is necessary in adolescents with primary ovarian insufficiency (POI) in order to avoid estrogen deficiency. The goal of this minirewiew... (Review)
Review
Hormone replacement therapy (HRT) is necessary in adolescents with primary ovarian insufficiency (POI) in order to avoid estrogen deficiency. The goal of this minirewiew is to present the different types of estrogens (17β-estradiol, estradiol valerate, ethinyl estradiol, and combined equine estrogens) as well as the different types of progestins available. In order to choose among the different types of HRTs, the features of each regimen are being discussed as well as their risks and their respective benefits. The differences between oral combined contraceptive pills and a dissociated regimen containing estrogen and progestins are emphasized. The different effects of HRTs, mainly on feminization, growth spurt, bone mass as well as cardiovascular risk, and the follow-up of these young patients are presented. HRT in adolescents and young adults with estrogen deficiency is necessary and should be continued until the age of natural menopause. Studies have so far essentially included children or adolescents with Turner syndrome. Therefore, studies on HRT including patients with POI and a normal karyotype are necessary.
Topics: Adolescent; Contraceptives, Oral, Hormonal; Estrogens; Female; Hormone Replacement Therapy; Humans; Primary Ovarian Insufficiency; Young Adult
PubMed: 28376481
DOI: 10.1159/000457125